Sui Xiong Cai
Vermogen: 39 M $ op 30-06-2026
Vermogen: 39 M $ op 30-06-2026
Sui Xiong Cai is currently Chief Executive Officer & Executive Director at IMPACT Therapeutics, Inc., a position started in 2025.
Formerly, Dr. Cai was Senior Director-Chemistry at EpiCept Corp.
from 2006 to 2009.
Education includes a doctorate from the University of Oregon, conferred in 1990.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 8.422.233 ( 2,98% ) | 39 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IMPACT THERAPEUTICS, INC | Algemeen Directeur | 01-06-2014 |
| Bedrijven | Functie | Einde |
|---|---|---|
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Corporate Officer/Principal | 01-01-2009 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. BiotechnologyHealth Technology Operates as a commercial-stage biotechnology company that develops anti-cancer therapies and pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau